Distinguished in Scleroderma

Ina Kotter

Otfried Mueller Str. 10, 
Tuebingen, BW, DE 
Distinguished in Scleroderma
Otfried Mueller Str. 10, 
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Ina Kotter practices in Tuebingen, Germany. Ms. Kotter is rated as a Distinguished expert by MediFind in the treatment of Scleroderma. Her top areas of expertise are Behcet Disease, Vasculitis, Systemic Sclerosis (SSc), Scleroderma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 182 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 27 articles in the study of Scleroderma.

Gender
Female

Locations

Otfried Mueller Str. 10, Tuebingen, BW 72076, Germany
Other Locations
Medizinische Universitätsklinik Abt. II, Hämatologie, Onkologie, Immunologie, Rheumatologie, Pulmologie, Otfried Müller Str. 10, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Study Protocol for a Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's Disease (AOSD) Including an Open-label Long Term Extension
Study Protocol for a Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's Disease (AOSD) Including an Open-label Long Term Extension
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)
Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)
Enrollment Status: Completed
Publish Date: May 17, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

182 Total Publications

From stroke via swollen joints to M. Whipple: case report from neurological rehabilitation and review of literature
From stroke via swollen joints to M. Whipple: case report from neurological rehabilitation and review of literature
Journal: Fortschritte der Neurologie-Psychiatrie
Published: August 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kotter's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile